U.S. FDA approves Genmab-AbbVie’s blood cancer therapy
By Mariam Sunny (Reuters) -The U.S. Food and Drug Administration has approved AbbVie Inc and Danish drugmaker Genmab’s blood cancer therapy for adult patients who have received at least two prior lines of treatment, the companies said on Friday. The therapy, epcoritamab, which will be sold under the brand name Epkinly, treats a type of …
U.S. FDA approves Genmab-AbbVie’s blood cancer therapy Read More »









